Pharmaceutical Sector

TASE Falls by 1.1% on Thursday

Tel Aviv Stock Exchange (TASE) fell by a 1.09% on Thursday to 1,230.88 points while the Tel Aviv-100 Index declined by 1.29% to 1,082.90.

The TechBlue 50 Index fell by 0.94% to 331.54 points. The decline is thought to be caused by the losses in the European markets. The Teva Pharmaceutical industries Ltd. fell by 3.5% after the strategic plan for it was published.

Kompanie: 

KV Pharmaceutical Aims to come out from Bankruptcy

KV Pharmaceutical Co., which has been in bankruptcy condition, has announced that it has been taking steps to overcome the problem. The Bridgeton-based drug maker told that they have received $85 million in the form of finances and has also entered into a settlement deal with a Massachusetts company for the drug Makena.

Kompanie: 

FDA Approves Extended Use of Drug Zytiga

It has been recently revealed that the FDA has approved the extended use of the drug Zytiga for men suffering from late stage of prostate cancer in which cancer keeps on increasing despite the provision of hormone therapy.

wirtschaft: 

Generell: 

Kompanie: 

Eli Lilly to Carry Out 2nd Clinical Trial for Alzheimer’s Drug

Eli Lilly, an Indianapolis drug maker, has come up with an experimental drug to treat mild cases of Alzheimer's. The drug named as solanezumab is said to have brought a hope to slow the memory decline among Alzheimer's.

Generell: 

Kompanie: 

GSK and Vodafone Enter New Alliance to Boost Vaccines Uptake in Africa

GlaxoSmithKline has decided a new target with Vodafone: to boost the uptake of childhood vaccinations in Africa with the help of some new innovative mobile technologies.

wirtschaft: 

Generell: 

GSK’s Expansion plans in Indian and Nigerian Markets

GlaxoSmithKline PLC, which is considered to be U. K.'s largest drug maker in terms of sales, has shown its interest in expanding its operation in India and Nigeria.

wirtschaft: 

Kompanie: 

Personen: 

Generell: 

Canada, Switzerland Give Clearance to Novartis Flu Vaccines

In consequent to no risk found, Novartis's flu vaccines were given clean chit by Canadian and Swiss health authorities. It has been confirmed by Swissmedic and Health Canada that all the anti-influenza vaccines are safe enough for humans.

wirtschaft: 

Personen: 

Kompanie: 

German Leading Drug-maker to Take Over Schiff

Recent reports have revealed that Bayer will be taking over Schiff Nutrition International, an important company, which markets nutritional supplements and vitamins across US and other countries. A merger deal has been signed between both the parties.

Kompanie: 

Pages

Subscribe to RSS - Pharmaceutical Sector